Form 4 for ASTH Astrana Health, Inc.
Accepted 2022-12-01 00:00:00 ET · period of report 2022-11-29 · accession 0001250853-22-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-01 | 2022-11-29 | ASTH | Young Albert WaiChow | Chief Administrative Off | M - OptEx | $10.49 | +55.2K | 1.14M | +5% | +$579.2K |
| DM | 2022-12-01 | 2022-11-29 | ASTH | Young Albert WaiChow | Chief Administrative Off | M - OptEx | — | -55.2K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-29 | M | A | 26,828 | $11.00 | 1,165,243 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-29 | M | A | 28,406 | $10.00 | 1,138,415 | D | — | — | |
| 3 | Derivative | Warrants to purchase Common Stock | 2022-11-29 | M | D | 26,828.01 | — | 0 | D | $11.00 · 2017-12-08 to 2022-12-08 | 26,828.01 Common Stock | (F2) On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 854,207 shares of common stock of the Issuer, (ii) a warrant to purchase 26,828.01 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 28,406.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 94,911.80 shares of common stock of the Issuer). |
| 4 | Derivative | Warrants to purchase Common Stock | 2022-11-29 | M | D | 28,406.13 | — | 0 | D | $10.00 · 2017-12-08 to 2022-12-08 | 28,406.13 Common Stock | (F2) On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 854,207 shares of common stock of the Issuer, (ii) a warrant to purchase 26,828.01 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 28,406.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 94,911.80 shares of common stock of the Issuer). |